Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.
Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.
Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.
Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...
1d
Medical Device Network on MSNFDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyoutThe intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results